Focus on: The Future of Pharma

Chronicling and predicting pharma's moves into digital

It was only a few years ago that digital innovation at pharmaceutical companies was the province of tiny siloed innovation groups, churning out the odd companion app for a drug. These days, innovation is front and center, with big pharma acquiring, partnering and innovating in-house in all kinds of areas from digital therapeutics to remote clinical trials to connected drug delivery devices. And that's not even mentioning the incredible transformative power of AI for drug development or pharma's increasing presence as strategic investors in promising digital health companies.

The question is no longer, "Will pharma innovate?"; it's "How is pharma innovating?". In the month of July, we'll take a closer look at the many answers to this question, as well as exploring what the changing face of pharma means for other healthcare stakeholders.

What you need to know

News

How Finland is teaming up with pharma to identify genetic variants in disease

by Laura Lovett

The country's FinnGen Project seeks to use its unique population bottleneck and cohesive health records to drive genetic insights.

News

From start to finish, drug development could benefit from cloud computing

by Nathan Eddy

From streamlining operations to fine-tuning optimal treatments, the technology makes a business case for pharma.

News

Security, control of data seen as key barriers to cloud adoption by pharma

by Nathan Eddy
There's continued resistance from many pharmaceutical industry executives, who think it's never possible to safely store sensitive data in the cloud.
 
News

UCB, DEARhealth team up on epilepsy initiative

by Laura Lovett

The companies will be using DEARhealth's platform, which integrates AI into EHRs to predict health outcomes. 

News

How the cloud enables innovation for pharma and life sciences

by Nathan Eddy
For all the potential benefits of SaaS-based analytics and AI apps, privacy concerns remain, slowing data sharing and suggesting the need for new approaches to cloud security.
 
News

Pharma's 2019 Q2 saw several clinical trial, medication management partnerships

by Laura Lovett

Pharma companies also continued to explore the promises of digital therapeutics. 

News

Clinical trials can benefit from cloud tech's data security, ease of access

by Nathan Eddy

A knee-jerk reaction to the technology would keep pharma from its benefits.

News

Pfizer working with Finnish tech startup to improve patient adherence

by Tammy Lovell

The pharmaceutical giant will offer Popit’s pill detection device to rheumatoid arthritis patients.

News

Allscripts purchases digital specialty prescription startup ZappRx

by Dave Muoio

A representative of the EHR vendor said that the cloud-based platform would be integrated within the Veradigm business unit.

News

Respect, communication key in pharma, digital collaborations

by Laura Lovett

At Health 2.0 Europe, pharma, patient and academic representatives weighed in on challenges of working together.

News

Nebula Genomics, Merck KGaA's EMD Serono partner on lung cancer pilot

by Laura Lovett

The blockchain-enabled startup's new pilot will rely on its database of sequenced genomes. 

News

Pharma won't benefit from digital innovation without anticipating its challenges

by Dave Muoio

At BIO 2019, Sanofi's chief medical and digital officer advised fellow pharma leaders on embracing new technologies and preparing for the challenges they'll bring.

News

How can pharma and tech come together for the benefit of patients?

by Tammy Lovell

Cross-sector collaboration creates enormous potential for people-centred healthcare innovations, but there are challenges to be overcome.

News

Roche, J&J regulatory leads weigh in on Pre-Cert's progress, challenges of regulating digital health

by Dave Muoio

At BIO 2019 in Philadelphia, a panel of industry experts discussed their experiences with the FDA's pilot program; ambiguities in drug, device and software pathways; and the hurdles digital health regulation has yet to properly address.

News

AbbVie employs MC10's wearables for new MS clinical trials

by Laura Lovett

The pair plans to use MC10's FDA-cleared wearable sensors, called BioStamp nPoint, to get insights into a patient's physiological data during the studies. 

News

Wearables, voice assistants face HIPAA hurdles but remain promising in clinical trials

by Laura Lovett

This morning MassBio hosted a panel on the use cases for the technology in clinical trials and beyond. 

News

AI-enabled monitoring, decision support platform Biofourmis raises $35M

by Laura Lovett

The Singaporean company will be moving its headquarters to Boston.